KHP Ventures

KHP Ventures is backed by King's Health Partners, which integrates King's College London with Guy's and St Thomas' and King's College Hospital NHS Foundation Trusts. This gives the fund direct access to clinical environments, patient populations, and NHS procurement pathways that most independent healthtech VCs cannot replicate without external partnerships. The trusts collectively serve approximately 2.5 million patients annually, creating a substantial pilot environment for portfolio companies.

Deal flow is sourced primarily through the clinical and research networks of King's Health Partners. Clinicians and academics identify workflow inefficiencies and emerging technologies with direct applicability inside the NHS, giving the fund early visibility into startups that align with real operational needs. This clinical-first sourcing model means portfolio companies are evaluated on utility inside a large teaching hospital system before market-fit analysis common at generalist funds.

The firm focuses on pre-seed and seed-stage investments, entering at the earliest point where clinical validation and an NHS pilot can materially de-risk the technology. This stage preference reflects the structural advantage of the fund: bringing portfolio companies into live clinical settings for iterative co-development with frontline practitioners before broader commercial rollout.

KHP Ventures is structured as a specialist venture capital firm, not a family office. It operates as an early-stage fund anchored within an academic health sciences center, investing external capital alongside the clinical and research resources of its institutional host. The structure more closely resembles a corporate venture arm embedded in a healthcare system than a traditional independent VC.

The firm's known posture is direct early-stage investing rather than fund-of-funds commitments. This aligns with its structural design: the value proposition to limited partners and portfolio companies rests on direct clinical access, which is meaningful at the company level but dilutes in a fund-of-funds model. No public record identifies fund commitment activity.